Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer

Lili Yang ab, Shanshan Liu ab, Jingjing Chu a, Shuang Miao ab, Kai Wang ab, Qingwei Zhang ab, Yingyi Wang a, Yadi Xiao a, Lina Wu ab, Yang Liu ab, Longjian Yu ab, Caihong Yu ab, Xiang Liu ab, Mingxing Ke ab, Zhen Cheng *c and Xilin Sun *ab
aNHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, Heilongjiang 150028, China
bTOF-PET/CT/MR Center, The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150028, China. E-mail: sunxl@ems.hrbmu.edu.cn; Tel: +86-451-88118600
cMolecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, USA. E-mail: zcheng@stanford.edu; Fax: +1-650-736-7925

Received 30th March 2022 , Accepted 30th March 2022

First published on 11th April 2022


Abstract

Correction for ‘Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer’ by Lili Yang et al., Biomater. Sci., 2021, 9, 443–455. DOI: 10.1039/D0BM00293C.


The authors regret that an incorrect image and scale bar were used in Fig. 4, as well as the incorrect scale in the figure caption. The authors also regret a spelling mistake in the Y axis of Fig. 6.
image file: d2bm90028a-f4.tif
Fig. 1 F-MPG or OH-MPG potently inhibits EGF-mediated cell migration and invasion. The migratory ability (the upper row) and invasive ability (the below row) of HCC827 cells induced by 20 ng mL−1 EGF were impaired by F-MPG or OH-MPG. (A) Representative images are shown (scale bars, 50 μm). Summary plots of the number of migrated cells (B and C) and invasive cells (D and E) under each condition for 24 h per field (counted using 15 microscopy fields from three separate experiments). *p < 0.05, **p < 0.01 and ***p < 0.001 for F-MPG or OH-MPG vs. PD153035.

image file: d2bm90028a-f6.tif
Fig. 2 The influence of tumor volume and body weight of F-MPG or OH-MPG in established HCC827 xenografts models. After randomly grouped nude mice bearing HCC827 tumors (n = 15 per group) were treated with vehicle control, PD153035 (50 mg kg−1), F-MPG (50 mg kg−1) or OH-MPG (50 mg kg−1) for 21 days, tumor volume (A) for F-MPG or OH-MPG treatment and body weight (B) were measured. Data shown are mean ± SD. ***p < 0.001 for PD153035, F-MPG or OH-MPG vs. control groups.

The corrected Fig. 4 and 6 are as shown here. The results and the conclusions of the manuscript remain unaffected.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2022
Click here to see how this site uses Cookies. View our privacy policy here.